FRANZINI, MARIA
 Distribuzione geografica
Continente #
EU - Europa 5.085
NA - Nord America 4.142
AS - Asia 1.678
SA - Sud America 310
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 5
Totale 11.253
Nazione #
US - Stati Uniti d'America 3.896
GB - Regno Unito 1.427
RU - Federazione Russa 1.068
IT - Italia 866
SG - Singapore 757
UA - Ucraina 481
PL - Polonia 323
DE - Germania 322
BR - Brasile 288
CN - Cina 285
VN - Vietnam 261
CA - Canada 227
HK - Hong Kong 196
DK - Danimarca 147
FI - Finlandia 98
SE - Svezia 93
IE - Irlanda 81
FR - Francia 80
KR - Corea 45
NL - Olanda 33
IN - India 28
BD - Bangladesh 17
TR - Turchia 17
EU - Europa 16
AT - Austria 14
IQ - Iraq 12
MX - Messico 10
UZ - Uzbekistan 10
CH - Svizzera 9
ES - Italia 9
ID - Indonesia 9
RO - Romania 9
JP - Giappone 8
SK - Slovacchia (Repubblica Slovacca) 8
TW - Taiwan 7
CO - Colombia 6
LT - Lituania 6
PK - Pakistan 6
ZA - Sudafrica 5
AR - Argentina 4
IL - Israele 4
MA - Marocco 4
SA - Arabia Saudita 4
VE - Venezuela 4
BE - Belgio 3
EC - Ecuador 3
IR - Iran 3
AU - Australia 2
BY - Bielorussia 2
CL - Cile 2
CR - Costa Rica 2
JO - Giordania 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
TN - Tunisia 2
AM - Armenia 1
BB - Barbados 1
BN - Brunei Darussalam 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GA - Gabon 1
GD - Grenada 1
HR - Croazia 1
KE - Kenya 1
KZ - Kazakistan 1
MY - Malesia 1
NG - Nigeria 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PW - Palau 1
RS - Serbia 1
SN - Senegal 1
SR - Suriname 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 11.253
Città #
Southend 1.186
Singapore 429
Chandler 412
Warsaw 322
San Mateo 287
Pisa 242
Fairfield 240
Woodbridge 235
Jacksonville 227
Ann Arbor 208
Beijing 196
Hong Kong 180
Houston 175
Ashburn 172
Wilmington 160
Cambridge 158
Dong Ket 140
Seattle 138
Dearborn 129
Falls Church 126
Boardman 109
Moscow 104
Stevenage 92
Beauharnois 86
Portsmouth 81
Dublin 76
Ottawa 75
Lawrence 74
The Dalles 63
Milan 59
Montréal 40
Seoul 32
Brooklyn 30
Munich 29
São Paulo 29
Rome 24
San Diego 24
Santa Clara 24
London 21
Redwood City 20
Chicago 18
Kansas City 18
Florence 17
Bologna 16
Old Bridge 14
San Francisco 14
Potenza 13
Los Angeles 12
Norwalk 12
Brasília 11
Helsinki 11
New York 11
Nuremberg 11
Turku 11
Fremont 10
Pavia 10
Tashkent 10
Lucca 9
Montreal 9
Turin 9
Bratislava 8
Catania 8
Foggia 8
Mountain View 8
Nanjing 8
Roccarainola 8
Shanghai 8
Augusta 7
Baghdad 7
Boston 7
Brescia 7
Casatenovo 7
Daejeon 7
Lappeenranta 7
Rio de Janeiro 7
Campinas 6
Hanover 6
Palermo 6
Timisoara 6
Tokyo 6
Toronto 6
West Jordan 6
Amsterdam 5
Belo Horizonte 5
Dongguan 5
Istanbul 5
Napoli 5
Pistoia 5
Antalya 4
Bari 4
Central District 4
Charlotte 4
Dhaka 4
Fayetteville 4
Frankfurt am Main 4
Hefei 4
Johannesburg 4
Lausanne 4
Mahwah 4
Medellín 4
Totale 6.932
Nome #
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 240
A High Performance Gel Filtration Chromatography Method for gamma-Glutamyltransferase Fraction Analysis 235
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 228
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 220
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 212
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results. 208
Gamma-glutammiltransferasi (GGT): biochimica clinica e patologia umana (Rassegna) 206
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 202
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 200
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 196
Marcatori di rimodellamento e fibrosi cardiaca 192
Indici di laboratorio di stress ossidativo. 191
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 187
Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. 184
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 182
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 181
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 177
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 176
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 171
State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Società Italiana di Biochimica Clinica (SIBIOC). 171
Rilevanza clinica e interpretazione dei marcatori biochimici nello scompenso cardiaco 169
Stato dell’arte dell’immunodosaggio dei peptidi natriuretici di tipo B 169
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 163
State of the Art of Immunoassay Methods for B-Type Natriuretic Peptides: an Update 148
Fractions of plasma gamma-glutamyltransferase in healthy individuals: Reference values. 147
Reference values for alanine aminotransferase, α-amylase, aspartate aminotransferase, γ-glutamyltransferase and lactate dehydrogenase measured according to the IFCC standardization during uncomplicated pregnancy. 146
Criteri per la valutazione delle caratteristiche analitiche e della utilità clinica dei nuovi biomarcatori cardiaci 146
Systematic differences between BNP immunoassays: comparison of methods using standard protocols and quality control materials 145
Correlates and reference limits of plasma gamma-glutamyltransferase fractions from the Framingham Heart Study. 144
The potential roles of gamma-glutamyltransferase activity in the progression of atherosclerosis and cardiovascular diseases. 143
A kinetic study of gamma-glutamyltransferase (GGT)-mediated S-nitrosoglutathione catabolism. 141
Circulating gamma-glutamyltransferase fractions in cirrhosis. 141
Serum gamma-glutamyltransferase: linking together environmental pollution, redox equilibria and progression of atherosclerosis? 140
State of the art of BNP and NT-proBNP immunoassays: The CardioOrmoCheck study. 139
Antioxidant capacity and protein oxidation in cerebrospinal fluid of amyotrophic lateral sclerosis. 138
Valutazione di un metodo di dosaggio del BNP nel sangue capillare 137
Forme molecolari della gamma-glutammiltransferasi: caratteristiche e biogenesis. 133
Valutazione delle prestazioni analitiche del nuovo metodo per il dosaggio dell’aldosterone che utilizza la piattaforma LIAISON: confronto con altri metodi immunometrcici e con la psettrometria di massa 132
State of the art of aldosterone immunoassays. 131
Contribution by polymorphonucleate granulocytes to elevated gamma-glutamyltransferase in cystic fibrosis sputum. 131
Gamma-glutamyltransferase, H(2)O(2)-induced apoptosis and expression of catalase. 129
Serum gamma-glutamyltransferase and intima-media thickness: pointing again to wall/lumen interactions in atherosclerosis. 127
Are standard cell culture conditions adequate for human umbilical cord blood mesenchymal stem cells? 127
Stato dell’arte del dosaggio dei peptidi BNP e NT-proBNP: il controllo di qualità esterno CardioOrmoCheck 124
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 124
Aortic valve disease and gamma-glutamyltransferase: accumulation in tissue and relationships with calcific degeneration. 122
Forme molecolari dela gamma-glutammiltransferasi: caratteristiche e biogenesi 121
Cystic fibrosis, elevated gamma-glutamyltransferase, and lung transplant outcome. 121
gamma-glutamiltransferasi e stress ossidativo. 118
A novel marker of progression for atherosclerosis and cardiovascular diseases: serum gamma-glutamyltransferase enzyme activity. 118
The S-thiolating activity of membrane gamma-glutamyltransferase: formation of cysteinyl-glycine mixed disulfides with cellular proteins and in the cell microenvironment. 116
Gamma-glutamyltransferase fractions in human plasma and bile: Characteristic and biogenesis 116
gamma-Glutamyltransferase activity in human atherosclerotic plaques – biochemical similarities with the circulating enzyme. 115
Method of detecting and separating serum gamma-glutamyltransferase (GGT) isoforms in a sample of biological fluid and the enzyme isoforms thereby obtained 114
Vitamin C supply to bronchial epithelial cells linked to glutathione availability in elf - A role for secreted gamma-glutamyltransferase. 113
PROCESS FOR DETERMINING S-NITROSOTHIOLS IN BIOLOGICALFLUIDS 111
Serum gamma-glutamyltransferase fractions in Myotonic Dystrophy type I: Differences with healthy subjects and patients with liver disease. 110
High-sensitivity gamma-glutamyltransferase fraction pattern in alcohol addicts and abstainers. 109
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 108
γ-Glutamyltransferase Fractions in Obese Subjects with Type 2 Diabetes: Relation to Insulin Sensitivity and Effects of Bariatric Surgery 108
Developmental variations of plasma gamma-glutamyltransferase fractions in humans and in laboratory mammalians. 105
Helicobacter, gamma-glutamyltransferase and cancer: further intriguing connections 104
Plasma membrane gamma-glutamyltransferase activity facilitates the uptake of vitamin C in melanoma cells. 102
Plasma gamma-glutamyltransferase (GGT) activity in inflammatory bowel disease: is the clinical laboratory plasma GGT assay sensitive enough for gastroenterology? 102
Modulation of cell growth and cisplatin sensitivity by membrane gamma-glutamyltransferase in melanoma cells. 101
Mechanisms and targets of the modulatory action of S-nitrosoglutathione (GSNO) on inflammatory cytokines expression. 101
Exogenous vs. endogenous gamma-glutamyltransferase activity: Implications for the specific determination of S-nitrosoglutathione in biological samples. 101
The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target? 100
gamma-Glutamyl transpeptidase catalyses the extracellular detoxification of cisplatin in a human cell line derived from the proximal convoluted tubule of the kidney. 98
Cultured human cells release soluble gamma-glutamyltransferase complexes corresponding to the plasma b-GGT 98
Gamma-glutamyltransferases: exploring the complexity of a multifunctional family of enzymes 96
Gamma-glutamyltransferase of cancer cells at the crossroads of tumor progression, drug resistance and drug targeting 93
Use of biomarkers to diagnose and manage cardiac amyloidosis 82
Biomarkers for growth prediction of abdominal aortic aneurysm: A step forward(?) 82
Preliminary study to evaluate the meaning of GGT fractions analysis in a population of workers previously exposed to asbestos 81
Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc? 78
Big gamma-glutamyltransferase is associated with epicardial fat volume and cardiovascular outcome in the general population 71
Highly Elevated Plasma γ-Glutamyltransferase Elevations: A Trait Caused by γ-Glutamyltransferase 1 Transmembrane Mutations 71
Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy 65
RNA-targeting and gene editing therapies for transthyretin amyloidosis 64
Pathophysiology of Cardiac Amyloidosis 56
Tetrameric Transthyretin as a Protective Factor Against Alzheimer’s Disease 55
Big and Free Fractions of Gamma-Glutamyltransferase: New Diagnostic Biomarkers for Malignant Mesothelioma? 52
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 49
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 47
The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism 43
Antithrombotic properties of Tafamidis: An additional protective effect for transthyretin amyloid cardiomyopathy patients 19
Gamma-glutamyltransferase independently predicts mortality and hospitalization for heart failure in cardiac transthyretin amyloidosis 10
Totale 11.319
Categoria #
all - tutte 66.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.981


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.649 85 151 83 118 105 162 181 83 109 101 147 324
2021/20221.122 88 222 40 77 27 28 128 219 66 132 18 77
2022/2023965 80 31 26 163 142 177 19 74 178 15 41 19
2023/2024543 50 24 76 27 17 74 47 44 19 21 48 96
2024/20253.229 46 36 148 77 121 199 506 964 234 143 513 242
2025/2026194 194 0 0 0 0 0 0 0 0 0 0 0
Totale 11.319